Use of Long Acting GnRH Antagonist to Prevent Ovarian HyperStimulation Syndrome (OHSS) in PCOS Women Undergoing COH for IVF

Trial Profile

Use of Long Acting GnRH Antagonist to Prevent Ovarian HyperStimulation Syndrome (OHSS) in PCOS Women Undergoing COH for IVF

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Apr 2016

At a glance

  • Drugs Degarelix (Primary) ; Cetrorelix
  • Indications Female infertility; Ovarian hyperstimulation syndrome; Polycystic ovary syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Apr 2016 Status changed from recruiting to completed.
    • 02 Dec 2013 Planned end date changed from 1 May 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov record.
    • 13 Nov 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top